We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protocol for Rapid Diagnosis of Mini-Strokes

By HospiMedica staff writers
Posted on 20 Jun 2006
An accelerated diagnostic protocol (ADP) has been developed to avoid the average three-day hospital stay for patients admitted for transient ischemic attack (TIA), commonly known as mini-strokes.

Researchers at Beaumont Hospital (Royal Oak, MI, USA) and Wayne State University (Detroit, MI, USA) conducted a study of 149 patients diagnosed with TIA. More...
The patients were randomly assigned to the ADP group or to an inpatient hospital bed. All patients received the same four diagnostic tests (carotid imaging, echocardiogram, cardiac monitoring, and serial clinical evaluation), but those in the ADP group received those tests more rapidly. The median length of stay for the ADP group was 25 hours vs 61 hours for the admitted patients.

Although more ADP patients were found to have stroke during their initial visit (seven vs four), a comparable number developed a subsequent stroke (three vs. two) or other major clinical event (four each). In summary, using an accelerated diagnostic protocol in an emergency observation unit was more efficient, less costly, resulted in shorter hospitals stays, and had comparable clinical outcomes compared to traditional inpatient admission. The results were reported at the annual meeting of the Society for Academic Emergency Medicine in May 2006 in San Francisco (CA, USA).

"I think the protocol offers a win-win-win situation,” said lead author Dr. Michael A. Ross. "The patient has a shorter stay, the hospital keeps more beds open, and the doctor gets answers more quickly.”

One of the difficulties with TIA patients is that by the time they reach the emergency room, their symptoms may have disappeared. Over 10% of these patients will suffer a stroke within 90 days, with 64% of those strokes being disabling, and 5% will experience a major cardiac event.



Related Links:
Beaumont Hospital
Wayne State University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.